The trademark application crisantaspase porton biopharma was filed by Porton Biopharma Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on May 9, 2021, and it was registered by office on August 16, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 5, 2021. Change of name and professional address of the trademark registration was recorded on May 23, 2022.